Wearable Sensors Set To Transform Cardiovascular Patient Care

Omron Healthcare and physIQ have collaborated to integrate Omron’s FDA-cleared device, HeartGuide, the first wearable blood pressure monitor into the pinpointIQ platform to monitor at-risk patients in an outpatient setting. The strategic collaboration aims to generate actionable clinical information for at-risk patients in an outpatient environment.

 

The Omron HeartGuide is said to be a first-of-its kind wearable blood pressure monitor made in the form of a wristwatch. It uses oscillometric technology to measure medically-accurate blood pressure readings and monitors activity and sleep. PhysIQ’s pinpointIQ solution is an enterprise-ready, device-agnostic platform designed to capture continuous multivariate physiological data from wearable sensors, apply FDA-cleared Artificial Intelligence-based analytics, and provide actionable clinical information to a patient’s care team.

Sponsored by Digi-Key

Industrial Ethernet Solutions from ADI Chronous™ Available Now from Digi-Key

ADI’s Chronous portfolio of edge-to-enterprise Industrial Ethernet connectivity solutions is designed to accelerate your path to Industry 4.0. The compatible and interoperable Industrial connectivity products enable best-in-class performance.

 

The initial implementation of the combined solution will be with a major Chicago-area integrated health system and focus on supporting post-discharge patients who have been hospitalized for either heart failure or heart attack. Patients will wear HeartGuide, which will transmit data through the physIQ mobile app to the pinpointIQ cloud-based platform. Clinicians will access patient data and analytics through the pinpointIQ user interface such that they can proactively manage their at-risk patients. For more information, visit Omron Healthcare and physIQ.

Suggested Articles

Gartner sees improvement for NAND, but non-memory declines will hurt smartphone and consumer electronics production.

Don’t miss these TV shows on the lighter side, recommended by engineers to help take your mind off the news.

Best answer: Not until a vaccine is widely deployed, maybe fall of 2021